KUALA LUMPUR: PMCK Bhd
has inked an underwriting agreement with Malacca Securities Sdn Bhd for its initial public offering (IPO) on the ACE Market of Bursa Malaysia, scheduled for the third quarter of 2025.
In a statement yesterday, the private healthcare service provider said the IPO comprised the issuance of 272.60 million new shares and an offer for sale of 32.72 million existing shares.
“Of the 272.60 million new shares, 54.53 million will be made available to the Malaysian public through balloting, and 43.62 million to eligible directors and employees, as well as persons who have contributed to the success of the company.
“Meanwhile, 136.33 million shares are reserved for private placement to selected bumiputra investors approved by the Investment, Trade and Industry Ministry, and 38.12 million shares by way of private placement to selected investors,” it said.
Pursuant to the underwriting agreement, Malacca Securities will underwrite a total of 98.15 million shares, which include 54.53 million shares made available to the Malaysian public and 43.62 million shares allocated to eligible persons.
It said PMCK plans to utilise the proceeds from its IPO for several strategic purposes, including the repayment of bank borrowings, particularly those incurred for the construction of Putra Medical Centre Kulim (PMC Kulim).
“PMC Kulim is designed with a focus on expanding clinical support services, particularly in outpatient care, to meet the evolving needs of the community,” it said.
Managing director Datuk Lee Gaik Cheng said over the past 30 years, it has grown to become a recognised name. — Bernama
